Investors

News Releases

News Releases

April 29, 2022
SANTA MONICA, Calif. , April 29, 2022 /PRNewswire/ --  Opiant Pharmaceuticals (NASDAQ: OPNT) was the subject of a fake news release issued on Friday, April 29, 2022 , that falsely stated Opiant announced a partnership with Hikma Pharmaceuticals, PLC.  Opiant had no knowledge of the press release